Search - tctmd.com

Displaying 481 - 500 of 808

Sort: Relevancy | Date

Presentation TCT 2013

FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-eluting Stent: Update on the FIH, TARGET I, and TARGET II Trials

Presenter: Bo Xu

October 27, 2013

Presentation TCT 2013

DESyneBD Novolimus-Eluting Coronary Stent: Device Design and Extended Clinical Study Follow-up

Presenter: Ricardo Costa

October 27, 2013

Presentation TCT 2013

DESolve Nx Novolimus-Eluting PLLA-Based BRS: First Report of the 6-month OCT and 12-month Clinical and Imaging Results

Presenter: Stefan Verheye

October 27, 2013

Presentation TCT 2013

DES Systems and Outcomes: Good and Bad

Presenter: Ziad Ali

October 27, 2013

Presentation TCT 2013

Demonstration of Clinical Superiority with a Bioresorbable Vascular Scaffold: The ABSORB IV Clinical Trial

Presenter: Gregg Stone

October 27, 2013

Presentation TCT 2013

Cre8 Stent Program Update (including the Diabetic Registry)

Presenter: Antonio Colombo

October 27, 2013

Presentation TCT 2013

Can Experimental Data Inform This Debate?(2)

Presenter: Juan Granada

October 27, 2013

Presentation TCT 2013

Can Experimental Data Inform This Debate?

Presenter: Juan Granada

October 27, 2013

Presentation TCT 2013

BioFreedom Stent and LEADERS FREE Trial

Presenter: Philip Urban

October 27, 2013

Presentation TCT 2013

Based on the Current Data, Durable Polymer DES Offer Early and Late Clinical Advantages!

Presenter: Sripal Bangalore

October 27, 2013

Presentation TCT 2013

Based on the Current Data, Bioabsorbable Polymer DES Offer Late Clinical Advantages!

Presenter: Stephan Windecker

October 27, 2013

Presentation TCT 2013

Bare Metal and Drug-Eluting Stents: Indications, Outcomes, Complications

Presenter: Sahil Parikh

October 27, 2013

Presentation TCT 2013

Amazonia Pax Program Update

Presenter: Jean Fajadet

October 27, 2013

Presentation TCT 2013

A Novel Magnesium-based BRS: Design Considerations and Bench Data

Presenter: Josiah Wilcox

October 27, 2013

Presentation TCT 2013

A Hollow-core Drug-filled Stent: Manufacturability, Elution Control and Progress Toward Clinical Studies

Presenter: Josiah Wilcox

October 27, 2013

Presentation TCT 2013

"Japan First, United States Faster:" A Breakthrough Business and Research Model for DES

Presenter: Mitchell Krucoff

October 27, 2013

Presentation TCT 2013

Gender-based Analysis of Everolimus-Eluting Stent Safety in the Bern-Rotterdam Cohort

Presenter: Giulio Stefanini, Lorenz R?ber, Michael Magro, Bindu Kalesan, Masanori Taniwaki, Cihan Simsek, Peter Wenaweser, Ron Van Domburg, Bernhard Meier, Peter Juni, Patrick Serruys, Stephan Windecker

January 31, 2013

Presentation TCT 2013

COMPARE II: One year Clinical Data for the treatment of small vessels (<2.75mm)

Presenter: SH Hofma, Peter Smits, A. J. van Boven, Mariano Valdes, Antonio Serra, Jean-Jacques Goy, V. Voudris, J. M. Vazquez, Ramiro Trillo, A.G. Vuillomenet, Ton Slagboom, Peter den Heijer

January 31, 2013

Presentation TCT 2013

Two-Year Outcomes Following Implantation of 32mm and 38mm Platinum Chromium Everolimus Eluting Element Stents in Long Coronary Lesions

Presenter: Paul Teirstein, Gregg Stone, Ian Meredith, Robert Feldman, Joseph Dens, Abram Rabinowitz, Christophe Dubois, Dominic Allocco, Keith Dawkins

January 31, 2013

Presentation TCT 2013

Two zotarolimus-eluting stent generations: a meta-analysis of 12 randomized trials versus other limus-eluting stents and an adjusted indirect comparison.

Presenter: Salvatore Cassese, Gjin Ndrepepa, Lamin King, Tomohisa Tada, Massimiliano Fusaro, Adnan Kastrati

January 31, 2013

Advertisement

FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-eluting Stent: Update on the FIH, TARGET I, and TARGET II Trials

DESyneBD Novolimus-Eluting Coronary Stent: Device Design and Extended Clinical Study Follow-up

DESolve Nx Novolimus-Eluting PLLA-Based BRS: First Report of the 6-month OCT and 12-month Clinical and Imaging Results

DES Systems and Outcomes: Good and Bad

Demonstration of Clinical Superiority with a Bioresorbable Vascular Scaffold: The ABSORB IV Clinical Trial

Cre8 Stent Program Update (including the Diabetic Registry)

Can Experimental Data Inform This Debate?(2)

Can Experimental Data Inform This Debate?

BioFreedom Stent and LEADERS FREE Trial

Based on the Current Data, Durable Polymer DES Offer Early and Late Clinical Advantages!

Based on the Current Data, Bioabsorbable Polymer DES Offer Late Clinical Advantages!

Bare Metal and Drug-Eluting Stents: Indications, Outcomes, Complications

Amazonia Pax Program Update

A Novel Magnesium-based BRS: Design Considerations and Bench Data

A Hollow-core Drug-filled Stent: Manufacturability, Elution Control and Progress Toward Clinical Studies

"Japan First, United States Faster:" A Breakthrough Business and Research Model for DES

Gender-based Analysis of Everolimus-Eluting Stent Safety in the Bern-Rotterdam Cohort

COMPARE II: One year Clinical Data for the treatment of small vessels (<2.75mm)

Two-Year Outcomes Following Implantation of 32mm and 38mm Platinum Chromium Everolimus Eluting Element Stents in Long Coronary Lesions

Two zotarolimus-eluting stent generations: a meta-analysis of 12 randomized trials versus other limus-eluting stents and an adjusted indirect comparison.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content